{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:47Z","timestamp":1740107807337,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10147-019-01419-9","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T03:48:24Z","timestamp":1550893704000},"page":"871-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-8935","authenticated-orcid":false,"given":"Daisuke","family":"Furuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Moriai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,23]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH et al (2003) Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 17:2318\u20132357","journal-title":"Leukemia"},{"key":"1419_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","volume":"108","author":"T Hughes","year":"2006","unstructured":"Hughes T, Deininger M, Hochhaus A et al (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108:28\u201337","journal-title":"Blood"},{"key":"1419_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122:872\u2013884","journal-title":"Blood"},{"unstructured":"National Comprehensive Cancer Network (NCCN) (2016) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Chronic Myelogenous Leukemia. Version 1. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf\n                    \n                  .\u00a0Accessed 24 May 2017","key":"1419_CR4"},{"key":"1419_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12185-017-2330-1","volume":"106","author":"N Usui","year":"2017","unstructured":"Usui N (2017) JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 4. Chronic myelogenous leukemia (CML)\/myeloproliferative neoplasms (MPN). Int J Hematol 106:591\u2013611","journal-title":"Int J Hematol"},{"key":"1419_CR6","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1007\/s00277-015-2315-1","volume":"94","author":"NC Cross","year":"2015","unstructured":"Cross NC, Hochhaus A, M\u00fcller MC (2015) Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization. Ann Hematol 94:S219\u2013S225","journal-title":"Ann Hematol"},{"key":"1419_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA et al (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10:1003\u20131005","journal-title":"Nat Methods"},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12185-017-2336-8","volume":"107","author":"Y Koizumi","year":"2018","unstructured":"Koizumi Y, Furuya D, Endo T et al (2018) Quantification of Wilms\u2019 tumor 1 mRNA by digital polymerase chain reaction. Int J Hematol 107:230\u2013234","journal-title":"Int J Hematol"},{"key":"1419_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3109\/10428194.2011.555569","volume":"52","author":"HG Goh","year":"2011","unstructured":"Goh HG, Lin M, Fukushima T et al (2011) Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay. Leuk Lymphoma 52:896\u2013904","journal-title":"Leuk Lymphoma"},{"key":"1419_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","volume":"16","author":"LJ Jennings","year":"2014","unstructured":"Jennings LJ, George D, Czech J et al (2014) Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR. J Mol Diagn 16:174\u2013179","journal-title":"J Mol Diagn"},{"key":"1419_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.leukres.2014.02.005","volume":"38","author":"I Iacobucci","year":"2014","unstructured":"Iacobucci I, Lonetti A, Venturi C et al (2014) Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. Leuk Res 38:581\u2013585","journal-title":"Leuk Res"},{"key":"1419_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1373\/clinchem.2016.262824","volume":"63","author":"M Alikian","year":"2017","unstructured":"Alikian M, Whale AS, Akiki S et al (2017) RT-qPCR and RT-digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia. Clin Chem 63:525\u2013531","journal-title":"Clin Chem"},{"key":"1419_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0022-1759(03)00223-0","volume":"278","author":"JA Whelan","year":"2003","unstructured":"Whelan JA, Russel NB, Whelan MA (2003) A method for the absolute quantification of cDNA using real time PCR. J Immunol Methods 278:261\u2013269","journal-title":"J Immunol Methods"},{"key":"1419_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1634\/theoncologist.2015-0337","volume":"21","author":"S Soverini","year":"2016","unstructured":"Soverini S, De Benedittis C, Mancini M et al (2016) Best practices in chronic myeloid leukemia monitoring and management. Oncologist 21:626\u2013633","journal-title":"Oncologist"},{"key":"1419_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12185-017-2334-x","volume":"107","author":"N Takahashi","year":"2018","unstructured":"Takahashi N, Tauchi T, Kitamura K et al (2018) Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study. Int J Hematol 107:185\u2013193","journal-title":"Int J Hematol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-019-01419-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T19:30:20Z","timestamp":1582399820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-019-01419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,23]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s10147-019-01419-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2019,2,23]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}